Veradermics to present hair loss drug trial results at research congress

May 27, 2026 7:30 AM

Veradermics (NYSE: MANE) will present results from its Phase 2/3 clinical trial of VDPHL01 at the 2026 World Congress for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found